Global Glaucoma Treatment Market to Witness Mounting Growth in Approaching Time

February 8, 2023/Industry News Global/ -- This new report from Stratview Research analyses the Global Glaucoma Treatment Market over the trend period from 2014 to 2019 and the forecast period from 2020 to 2026. The insights of the report shall enable informed decision-making and strategy formulation for the near future to capitalize on the opportunities.
Global Glaucoma Treatment Market Overview:
The Global Glaucoma Treatment Market is projected to grow from USD xx million in 2020 to USD xx million by 2026 at a CAGR of over 7.4% during the forecast period.
Segment Analysis
Drug Class Trends
Based on drug class, the global glaucoma treatment market has been categorized into prostaglandin analogs, beta-blockers, alpha agonists, carbonic anhydrase inhibitors, others.
• Among these, the prostaglandin analogs segment garnered the highest market share in 2020 and is likely to register a healthy CAGR during the review period.
• This is mainly attributed to the growing number of geriatric patients with glaucoma and prostaglandin analogs are administered as an eye drop, thus ease of using the drug is likely to augment the growth of prostaglandin analogs.
Regional Trends
By region, the North American market witnessed the highest market share in 2020 and is projected to grow at a robust CAGR during the review period.
• This can be attributed to rising healthcare expenditure, the presence of major healthcare companies, and the increasing senior population, promulgate the product region in the region.
• Moreover, growing cases of glaucoma in the region coupled with better healthcare infrastructure further boost the regional growth.
COVID-19 Impact on Global Glaucoma Treatment Market
The ongoing COVID-19 pandemic has significantly affected the glaucoma treatment industry due to the shift of medical treatment from glaucoma and other health condition towards the treatment of coronavirus-affected patients. Many government healthcare facilities have recognized glaucoma as an elective. Thus, all the surgeries associated with this condition were postponed or canceled across the globe due to the outbreak of the COVID-19 pandemic.
Get access to a deeper coverage of the impact of COVID-19 on this Market here: https://www.stratviewresearch.com/Request-Sample/1711/glaucoma-treatment-market.html#for
Regional analysis:
Regional Trends
By region, the North American market witnessed the highest market share in 2020 and is projected to grow at a robust CAGR during the review period.
• This can be attributed to rising healthcare expenditure, the presence of major healthcare companies, and the increasing senior population, promulgating the product region in the region.
• Moreover, growing cases of glaucoma in the region coupled with better healthcare infrastructure further boost regional growth.
About Stratview Research
Stratview Research is a global market intelligence firm providing wide range of services including syndicated market reports, custom research and sourcing intelligence across industries, such as Advanced Materials, Aerospace & Defense, Automotive & Mass Transportation, Consumer Goods, Construction & Equipment, Electronics and Semiconductors, Energy & Utility, Healthcare & Life Sciences, and Oil & Gas.
For enquiries,
Contact:
Stratview Research
E-mail: [e-mail]
Direct: [phone]